CLU and Alzheimer disease: Multiplex assays have identified increased levels of clusterin in plasma, differentiating AD from controls, and modeling with relevant co-variables indicated clusterin, Complement Factor I, and MAC to be different in MCI-converters from non-converters, while plasma Complement Factor I levels were shown to be associated with brain atrophy [440].